Framework for the evaluation of new tests for tuberculosis infection
Open Access
- 21 January 2021
- journal article
- research article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 58 (2) , 2004078
Abstract
The scale-up of tuberculosis (TB) preventive treatment (TPT) must be accelerated to achieve the targets set by the United Nations High-level Meeting on TB and the End TB Strategy. The scale-up of effective TPT is hampered by concerns about operational challenges to implement the existing tests for TB infection. New simpler tests could facilitate the scale-up of testing for TB infection. We present a framework for evaluation of new immunodiagnostic tests for the detection of TB infection, with an aim to facilitate their standardised evaluation and accelerate adoption into global and national policies and subsequent scale-up. The framework describes the principles to be considered when evaluating new tests for TB infection and provides guidance to manufacturers, researchers, regulators and other users on study designs, populations, reference standards, sample size calculation and data analysis and it is also aligned with the Global Strategy for TB Research and Innovation adopted by the World Health Assembly in 2020. In addition, we briefly describe technical issues that should be considered when evaluating new tests, including the safety for skin tests, costs incurred by patients and the health system, and operational characteristics.Keywords
This publication has 20 references indexed in Scilit:
- First evaluation of QuantiFERON-TB Gold Plus performance in contact screeningEuropean Respiratory Journal, 2016
- Interferon-Gamma Release Assays for the Diagnosis of Tuberculosis: A Systematic Review and Meta-analysisLung, 2016
- Management of latentMycobacterium tuberculosisinfection: WHO guidelines for low tuberculosis burden countriesEuropean Respiratory Journal, 2015
- LatentMycobacterium tuberculosisInfectionNew England Journal of Medicine, 2015
- Towards tuberculosis elimination: an action framework for low-incidence countriesEuropean Respiratory Journal, 2015
- IFN-γ Release Assay Conversions and Reversions. Challenges with Serial Testing in U.S. Health Care WorkersAnnals of the American Thoracic Society, 2014
- Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysisThe Lancet Infectious Diseases, 2012
- Bio‐creep in non‐inferiority clinical trialsStatistics in Medicine, 2010
- Method agreement analysis: A review of correct methodologyTheriogenology, 2010
- Within-Subject Variability and Boosting of T-Cell Interferon-γ Responses after Tuberculin Skin TestingAmerican Journal of Respiratory and Critical Care Medicine, 2009